Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -415175.00% is 1664% below its 1-year average of -23530.00%, near the low end of its 1-year range (-415175.00%–0.00%).
1664.45% below its 12-month average of -23530.00%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
-415175.00%
OPERATING MARGIN AVG TTM
-23530.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-1664.45%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 604 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Genelux Corporation
Market Cap
$114.34M
Operating Margin
-415175.00%
TTM Avg
-23530.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$114.62M
Operating Margin
-137.12%
TTM Avg
-134.83%
3Y Avg
-112.12%
5Y Avg
-90.73%
Market Cap
$114.23M
Operating Margin
-1054.82%
TTM Avg
-1057.23%
3Y Avg
-4752.68%
5Y Avg
-4082.42%
Market Cap
$116.54M
Operating Margin
-1220.49%
TTM Avg
-1443.83%
3Y Avg
-998.11%
5Y Avg
-830.42%
Market Cap
$111.86M
Operating Margin
-255.05%
TTM Avg
-370.20%
3Y Avg
-218.02%
5Y Avg
-145.34%
Market Cap
$117.11M
Operating Margin
-477.46%
TTM Avg
-238.73%
3Y Avg
-136.84%
5Y Avg
-91.23%
Market Cap
$111.93M
Operating Margin
-265.64%
TTM Avg
-359.98%
3Y Avg
-411.27%
5Y Avg
-4203.28%
Market Cap
$111.14M
Operating Margin
-33.18%
TTM Avg
-17.71%
3Y Avg
-9.45%
5Y Avg
-4.00%
Market Cap
$117.21M
Operating Margin
-754.08%
TTM Avg
-1999.61%
3Y Avg
-1887.55%
5Y Avg
-2072.97%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Genelux Corporation (GNLX) | $114.34M | -415175.00% | -23530.00% | 0.00% | 0.00% |
| MaxCyte, Inc. (MXCT)vs › | $114.62M | -137.12% | -134.83% | -112.12% | -90.73% |
| Lucid Diagnostics Inc. (LUCD)vs › | $114.23M | -1054.82% | -1057.23% | -4752.68% | -4082.42% |
| Caribou Biosciences, Inc. (CRBU)vs › | $116.54M | -1220.49% | -1443.83% | -998.11% | -830.42% |
| Coya Therapeutics, Inc. (COYA)vs › | $111.86M | -255.05% | -370.20% | -218.02% | -145.34% |
| LENZ Therapeutics, Inc. (LENZ)vs › | $117.11M | -477.46% | -238.73% | -136.84% | -91.23% |
| Foghorn Therapeutics Inc. (FHTX)vs › | $111.93M | -265.64% | -359.98% | -411.27% | -4203.28% |
| BGM Group Ltd. (BGM)vs › | $111.14M | -33.18% | -17.71% | -9.45% | -4.00% |
| Insight Molecular Diagnostics Inc. (IMDX)vs › | $117.21M | -754.08% | -1999.61% | -1887.55% | -2072.97% |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $109.42M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
-7075.0%
Operating Margin
-415175.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | -117650.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | -101437.50% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | -3801.18% |
| 2022-12-31 | -4550.00% |
| 2022-09-30 | 57.67% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
